New York State Common Retirement Fund’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

New York State Common Retirement Fund’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-411	Closed	-$2K	–	3484
2022 Q2	$2K	Sell	411 -21,595	-98%	-$61.5K	﹤0.01%	3299
2022 Q1	$105K	Hold	22,006	–	–	﹤0.01%	3008
2021 Q4	$80K	Sell	22,006 -49	-0.2%	-$261	﹤0.01%	3138
2021 Q3	$177K	Sell	22,055 -8,945	-29%	-$88.2K	﹤0.01%	2957
2021 Q2	$352K	Buy	+31,000	New	+$311K	﹤0.01%	2777
2015 Q3	–	Sell	-118	Closed	-$75K	–	3204
2015 Q2	$75K	Buy	+118	New	+$62.7K	﹤0.01%	3158

Other funds holding VIRX

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MCM

MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

New York State Common Retirement Fund's VIRX Position: Q3 2022 in Review

New York State Common Retirement Fund sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q3 2022, closing a stake of 411 shares — an estimated $2K sold.

New York State Common Retirement Fund first reported a position in VIRX in Q2 2015 and held it in 6 quarters. The position peaked at $352K in Q2 2021. 59 funds tracked by Wall St. Rank hold VIRX as of Q3 2022.

New York State Common Retirement Fund reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
New York State Common Retirement Fund sold 411 Viracta Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $2K.
New York State Common Retirement Fund first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2015 and held it in 6 quarters.
New York State Common Retirement Fund's Viracta Therapeutics, Inc. Common Stock position peaked at $352K in Q2 2021.
59 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q3 2022.

Based on New York State Common Retirement Fund's 13F filing for Q3 2022, filed 8 Nov 2022.